Demographics, clinical features and outcome of COVID-19 patients admitted to tertiary care hospital.

  • Jagadevi Associate Professor, Department of Microbiology, Basaveshwara Medical College and Hospital, Chitradurga, Karnataka, Indi
  • A Sumanta Associate Professor, Department of Microbiology, Basaveshwara Medical College and Hospital, Chitradurga, Karnataka, Indi
  • DS Shubh Professor and Head, Department of Microbiology, Basaveshwara Medical College and Hospital, Chitradurga, Karnataka, India
  • KS Sudhindra Professor, Department of Microbiology, Basaveshwara Medical College and Hospital, Chitradurga, Karnataka, India
  • B Saipriya Associate Professor, Department of Microbiology, Basaveshwara Medical College and Hospital, Chitradurga, Karnataka, India
Keywords: Coronavirus disease 2019(COVID-19),Comorbidities, Symptomatic and Asymptomatic patients ,Mortality.

Abstract

Background : In December 2019, a novel coronavirus (SARS-CoV-2) emerged in China and rapidly spread globally including India and has presented major challenges to health care settings, clinical laboratories, from initial diagnosis to patient monitoring and treatment. The characteristic demographic, clinical observations and outcomes of Novel Coronavirus disease 2019 (COVID-19) have been reported from different countries.  Objectives: The present study was aimed to describe the clinical and demographic characteristics and outcomes of COVID-19 patient. Materials and methods: This retrospective study was conducted for a period of six months from September 2020 to February 2021 at Microbiology Department, Molecular laboratory Basaveshwara medical college and hospital(BMCH),Chitradurga. All clinically suspected RTPCR positive COVID-19 Patients aged more than 18 years admitted in COVID Care centre,BMCH were  included in the study. Demographic, clinical, laboratory, treatment and outcome data were extracted from hospital medical records section and analysed. Results:  Total of 1368 RTPCR positive COVID-19 patients data were analysed. The mean age of all patients was 38.9 years (± 12.5 SD). Males(59.3%) were slightly higher in number than females (40.6%). Co-morbidities associated with COVID-19 were, Hypertension in 268(19.5%), diabetes in 238 (17.3%),COPD in 84(6.1%), chronic kidney disease  in 34 (2.4%) and chronic liver disease  in 19 (1.3%) patients. Of the 1368 COVID-19 patients, 723(  52.9% ) were asymptomatic, 645( 47.2%) symptomatic , 289 (21.1%)  patients  had  intensive care unit (ICU)admission,1084(79.2%) cured  from COVID-19 and discharged and 191(13.6%) cases had mortality. Conclusion: The observation from our study suggests  that more number of asymptomatic patients with COVID-19  and patients with comorbidities were more vulnerable to disease severity and critical condition.  Early categorisation of patients and management based on set protocol resulted in good outcomes and low mortality of cases.

Downloads

Download data is not yet available.

References

1) Khizroeva J.Kh., Makatsariya A.D., Bitsadze V.O., Tretyakova M.V., Slukhanchuk E.V., Elalamy I., et al. Laboratory monitoring of COVID-19 patients and importance of coagulopathy markers. Obstetrics, Gynecology and Reproduction. 2020; 14(2):132–147.
2) WHO Clinical management of COVID-19: living guidance. 25 January 2021
3) Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
4) WHO Diagnostic testing for SARS-CoV-2: Interim guidance. 11 September 2020 Med. World Health Organization. Clinical management of COVID-19. Available from: https://www.who.int/publicationsdetail-redirect/clinical-management-of-covid-19, accessed on June 9, 2020.
5) Lippi G, Plebani M. A modern and pragmatic definition of laboratory medicine. Clinical Chemistry and Laboratory Medicine.2020;58(8): 1171. doi: 10.1515/ cclm-2020-0114.
6) T.P. Velavan, C.G. Meyer. Mild versus severe COVID-19: Laboratory markers. International Journal of Infectious Diseases 95 (2020) 304–307.
7) Reza Alizadeh-Navaei , Majid Saeedi , Reza Valadan et al. Laboratory Abnormalities in Patients with COVID-19 in Mazandaran Province, Iran. Iran Red Crescent Med J. 2020 July; 22(7).
8) Emami A., et al., Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis. Arch Acad Emerg Med, 2020. 8(1): p. e35.
9) Anant Mohan , Pawan Tiwari , Sushma Bhatnagar , Ankit Patel , Abhishek Maurya , Lalit Dar et al. Clinico-demographic profile & hospital outcomes of COVID-19 patients admitted at a tertiary care centre in north India. Indian J Med Res 152, July & August 2020, pp 61-69.
10) Xiao-Wei Xu, Xiao-Xin Wu, Xian-Gao Jiang, Kai-Jin Xu, Ling-Jun Ying, Chun-Lian Ma. et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 2020;368:m606.
11) Shiv Lal Soni , Kamal Kajal , L.N. Yaddanapudi , Pankaj Malhotra , Goverdhan Dutt Puri , Ashish Bhalla.et al. Demographic & clinical profile of patients with COVID-19 at a tertiary care hospital in north India. Indian J Med Res 153, January & February 2021, pp 115-125.

12) Huan Han, Zaichao Xu, Xiaoming Cheng, Youquan Zhong, Li Yuan, Fubing Wang.et al. Descriptive, Retrospective Study of the Clinical Characteristics of Asymptomatic COVID-19 Patients . American society for microbiology.2020 Volume 5 Issue 5. mSphere5: e00922-20.
13) Panagiotis Paliogiannis , Angelo Zinellu, Valentina Scano , Giulia Mulas , Giacomo De Riu , Rosa M Pascale.et al. Laboratory test alterations in patients with COVID-19 and non COVID-19 interstitial pneumonia: a preliminary report . J Infect Dev Ctries 2020; 14(7):685-690.
14) Elena Aloisio, Mariia Chibireva, Ludovica Serafini, Sara Pasqualetti, Felicia S. Falvella, Alberto Dolci .et al. A Comprehensive Appraisal of Laboratory Biochemistry Tests as Major Predictors of COVID-19 Severity Arch Pathol Lab Med. 2020;144:1457–1464;
15) Danying Liao*, Fen Zhou*, Lili Luo, Min Xu, Hongbo Wang, Jiahong Xia et al. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study. Lancet Haematol 2020; 7: e671–78.
How to Cite
Jagadevi, A Sumanta, DS Shubh, KS Sudhindra, & B Saipriya. (2022). Demographics, clinical features and outcome of COVID-19 patients admitted to tertiary care hospital. Tropical Journal of Pathology and Microbiology, 8(1), 6-12. Retrieved from https://pathology.medresearch.in/index.php/jopm/article/view/598
Issue
Vol 8 No 1 (2022): Jan-Feb
Section
Original Article

Copyright (c) 2022 Author (s). Published by Siddharth Health Research and Social Welfare Society

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.